Dr Peter Varnai is principal consultant in the UK office of Technopolis Group and responsible for the Group’s Health Business Unit. Peter has over 15 years of experience in research, education and consulting in the area of health and life sciences. He has recently consulted on vaccination research, access to medicine, clinical trial data sharing, cross-border healthcare, industry-academia partnerships, drug discovery, and on the uptake of mobile technologies in the healthcare sector. Peter’s strengths are in strategic work related to health research policy and innovation. Peter applies methods ranging from quantitative modelling to qualitative techniques including interviews and case studies.
Peter is an experienced consultant and project manager with recent relevant work including the Evaluation of the impact of the European Union’s Research Framework Programmes on poverty related and neglected diseases with case studies in Tanzania and Burkina Faso; Ex-post evaluation of the Programme for Global Health and Vaccination Research for the Research Council of Norway; evaluation for DFID to assess the capacity building model of the International Union Against TB and Lung Disease improve public health and health service delivery in countries overburdened with infectious diseases. Peter is also experienced in leading peer-review panels, for example to evaluate the Dasman Diabetes on scientific, governance, financial, training and human resources for the Institute for the Kuwait Foundation for the Advancement of Sciences. Previously he has contributed to several studies on drug discovery R&D programmes, and advised clients how to improve effectiveness and drive innovation.
Prior to joining Technopolis, Peter worked as a Senior Lecturer at the University of Sussex. During this time, he designed and directed an interdisciplinary MSc programme in Chemical Biology, and also led a research group that developed computer simulation methods to understand disease pathways for the Translational Drug Discovery Group. Before that he was a Wellcome Trust International Prize research fellow at the University of Cambridge and at the CNRS in Paris. He is a Fellow of the Royal Society of Chemistry (UK), member of the American Chemical Society (USA) and has published widely in leading scientific journals.
Peter obtained a MEng (chemical engineering) and PhD from Budapest University of Technology and Economics, a DPhil from the University of Oxford, and an MBA from Imperial College Business School. Peter works in English, French, and Hungarian.